Gary W. Middleton
Birmingham, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications
Severe Toxic Epidermal Necrolysis Following Combination Ipilimumab-Nivolumab Therapy for Pleural Mesothelioma, Successfully Treated With Ruxolitinib: A Case Report.
Journal: Clinical lung cancer
Published: February 06, 2026
Neoadjuvant chemoimmunotherapy in non-small cell lung cancer: evolving resectability criteria, biomarker-driven postoperative management, and emerging therapeutic strategies.
Journal: Journal for immunotherapy of cancer
Published: January 17, 2026
The anti-CD33 antibody drug conjugate gemtuzumab ozogamicin depletes and functionally resets CD33+ myeloid-derived suppressor cells in patients with metastatic cancer: a phase 2 single-arm, open-label trial.
Journal: Journal of leukocyte biology
Published: December 12, 2025
Final results of ANICCA-Class II, a single arm, open-label phase II trial assessing nivolumab in tissue-specific class II expressing metastatic microsatellite stable colorectal cancer, with a parallel assessment of the immunoscore-immune checkpoint as a predictive biomarker for single-agent anti-PD-1.
Journal: Journal for immunotherapy of cancer
Published: December 01, 2025
Experimental Cancer Medicine Centre (ECMC) network proposal for a consensus gene panel for pan-cancer sequencing: a Delphi methodology.
Journal: British journal of cancer
Published: June 18, 2025
Letter to editor: Complementary perspectives on B cell regulatory phenotypes in cancer.
Journal: Frontiers in immunology
Published: June 15, 2025
Circulating immunoregulatory B cell and autoreactive antibody profiles predict lack of toxicity to anti-PD-1 checkpoint inhibitor treatment in advanced melanoma.
Journal: Journal for immunotherapy of cancer
Published: May 13, 2025
Pancreatic Adenocarcinoma: Long-Term Outcomes of Adjuvant Therapy in the ESPAC4 Phase III Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 05, 2024
The dual role of TIGIT in regulatory and effector T cells in chronic liver disease.
Journal: JHEP reports : innovation in hepatology
Published: November 05, 2024
Author Correction: Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.
Journal: Nature reviews. Clinical oncology
Published: October 07, 2024
Neoadjuvant immunotherapy for dMMR and pMMR colorectal cancers: therapeutic strategies and putative biomarkers of response.
Journal: Nature reviews. Clinical oncology
Published: September 04, 2024
The impact of the immunological context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 04, 2024
Last Updated: 09/26/2026